Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.06). Revenue for the quarter came in at $8.3 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Independence Realty Trust (IRT) files mixed shelf